We are live on ! Find out more
WX

WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX

Delisted

WX was delisted on the 10th of December, 2015.

151 hedge funds and large institutions have $2.42B invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2015 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 45 increasing their positions, 66 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more funds holding in top 10

Funds holding in top 10: 1014 (+4)

2% less capital invested

Capital invested by funds: $2.48B → $2.42B (-$59.2M)

7% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 29

2% less funds holding

Funds holding: 154151 (-3)

32% less repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 66

61% less call options, than puts

Call options by funds: $10.2M | Put options by funds: $26.3M

Holders
151
Holders Change
-3
Holders Change %
-1.95%
% of All Funds
4.22%
Holding in Top 10
14
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+40%
% of All Funds
0.39%
New
27
Increased
45
Reduced
66
Closed
29
Calls
$10.2M
Puts
$26.3M
Net Calls
-$16.1M
Net Calls Change
-$6.35M
Name Holding Trade Value Shares
Change
Change in
Stake
Walleye Trading
176
Walleye Trading
New York
-$19.5K -462 Closed
BRWM
177
B. Riley Wealth Management
Tennessee
-$19K -450 Closed
GWM
178
Gupta Wealth Management
California
-$6K -150 Closed
FANJ
179
Financial Architects (New Jersey)
New Jersey
-$4K -106 Closed
JG
180
Jefferies Group
New York
-$3K -68 Closed
RIA
181
Regal Investment Advisors
Michigan
-$2K -63 Closed

WX Hedge Fund Activity: Q3 2015 in Review

151 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q3 2015, worth a combined $2.42B — down 2.4% from $2.48B a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of WX and 27 opened new positions — a net loss of 2 holders — while 66 trimmed existing stakes and 45 added.

The largest buyer was Taconic Capital Advisors, adding an estimated $88.6M. The largest seller was Fidelity International, cutting an estimated $110M.

  • 151 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q3 2015, down from 154 in Q2 2015.
  • Funds reported $2.42B of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q3 2015, down 2.4% quarter-over-quarter.
  • 27 funds opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q3 2015 and 29 closed out, a net change of -2 holders.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q3 2015 was Taconic Capital Advisors, an estimated $88.6M added.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q3 2015 was Fidelity International, an estimated $110M sold.

Based on aggregated 13F filings for Q3 2015.